Intratumoral Injection of LTX-315 in Combination With Pembrolizumab in Advanced Melanoma
Condition(s):Advanced MelanomaLast Updated:November 9, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Advanced MelanomaLast Updated:November 9, 2023Active, not recruiting
Condition(s):Soft Tissue SarcomaLast Updated:December 5, 2023Completed
Condition(s):Cancer; Melanoma; Breast Cancer; Head and Neck Cancer; Lymphoma; Triple-Negative Breast CancerLast Updated:October 3, 2018Completed
Condition(s):Non-bullous ImpetigoLast Updated:April 28, 2014Completed
Condition(s):Gram-positive, Skin Infections; Mild Eczema/Dermatoses; Atopic DermatitisLast Updated:February 16, 2011Completed
Condition(s):CarcinomaLast Updated:January 11, 2012Completed
Condition(s):Nasal Carriers MRSALast Updated:June 8, 2011Completed
Condition(s):Cancer With Transdermal Accessible TumourLast Updated:February 11, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.